57.85
price up icon1.51%   0.86
pre-market  プレマーケット:  57.59   -0.26   -0.45%
loading
前日終値:
$56.99
開ける:
$57.8
24時間の取引高:
2.19M
Relative Volume:
1.04
時価総額:
$9.05B
収益:
$1.22B
当期純損益:
$77.95M
株価収益率:
118.25
EPS:
0.4892
ネットキャッシュフロー:
$224.06M
1週間 パフォーマンス:
-0.03%
1か月 パフォーマンス:
-15.76%
6か月 パフォーマンス:
+9.32%
1年 パフォーマンス:
-3.78%
1日の値動き範囲:
Value
$56.92
$58.07
1週間の範囲:
Value
$54.59
$59.06
52週間の値動き範囲:
Value
$46.01
$72.16

Bio Techne Corp Stock (TECH) Company Profile

Name
名前
Bio Techne Corp
Name
セクター
Healthcare (1106)
Name
電話
612-379-8854
Name
住所
614 MCKINLEY PL N E, MINNEAPOLIS, MN
Name
職員
3,100
Name
Twitter
@biotechne
Name
次回の収益日
2024-10-30
Name
最新のSEC提出書
Name
TECH's Discussions on Twitter

Compare TECH vs VRTX, REGN, ARGX, ALNY, ONC

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
TECH
Bio Techne Corp
57.85 8.92B 1.22B 77.95M 224.06M 0.4892
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.89 120.48B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
787.50 81.05B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
749.56 46.33B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
327.30 42.26B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
299.02 32.87B 5.36B 287.73M 924.18M 2.5229

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-03 アップグレード RBC Capital Mkts Sector Perform → Outperform
2025-08-21 アップグレード Citigroup Neutral → Buy
2025-07-22 再開されました Stephens Overweight
2025-07-09 開始されました TD Cowen Buy
2025-05-30 開始されました Wells Fargo Overweight
2025-04-09 ダウングレード KeyBanc Capital Markets Overweight → Sector Weight
2025-03-18 開始されました Evercore ISI Outperform
2025-02-19 ダウングレード Robert W. Baird Outperform → Neutral
2024-05-22 ダウングレード Citigroup Buy → Neutral
2024-02-08 開始されました Scotiabank Sector Outperform
2024-02-02 ダウングレード Stifel Buy → Hold
2023-12-07 開始されました UBS Buy
2023-08-28 開始されました William Blair Outperform
2023-01-10 アップグレード Wells Fargo Underweight → Equal Weight
2022-12-14 開始されました Deutsche Bank Buy
2022-12-12 アップグレード Citigroup Neutral → Buy
2022-12-07 開始されました RBC Capital Mkts Sector Perform
2022-08-25 開始されました Credit Suisse Outperform
2022-04-25 ダウングレード Wells Fargo Equal Weight → Underweight
2021-09-15 アップグレード KeyBanc Capital Markets Sector Weight → Overweight
2021-03-08 アップグレード Stephens Equal-Weight → Overweight
2021-02-23 アップグレード Stifel Hold → Buy
2021-01-25 繰り返されました The Benchmark Company Buy
2020-11-10 開始されました KeyBanc Capital Markets Sector Weight
2020-09-30 開始されました Atlantic Equities Overweight
2020-07-15 ダウングレード Stephens Overweight → Equal-Weight
2020-05-27 ダウングレード Stifel Buy → Hold
2020-05-14 開始されました The Benchmark Company Buy
2020-01-08 再開されました Stephens Overweight
2020-01-08 開始されました Wells Fargo Equal Weight
2020-01-07 開始されました Citigroup Neutral
2019-11-15 開始されました Stifel Buy
2019-07-02 アップグレード Janney Neutral → Buy
2019-01-14 アップグレード Stephens Equal-Weight → Overweight
2018-10-31 ダウングレード Craig Hallum Buy → Hold
2018-10-17 開始されました Goldman Neutral
2018-06-15 開始されました Argus Buy
2017-07-13 開始されました Wells Fargo Market Perform
2017-02-09 開始されました Citigroup Buy
2017-01-18 開始されました Deutsche Bank Buy
2016-11-10 再開されました Leerink Partners Outperform
2015-01-21 繰り返されました Robert W. Baird Outperform
2013-09-20 アップグレード Robert W. Baird Neutral → Outperform
すべてを表示

Bio Techne Corp (TECH) 最新ニュース

pulisher
Mar 04, 2026

TECH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 04, 2026
pulisher
Mar 04, 2026

TD Asset Management Inc Acquires 36,424 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Cresset Asset Management Boosts Stake in Bio-Techne - National Today

Mar 04, 2026
pulisher
Mar 04, 2026

Cresset Asset Management LLC Increases Position in Bio-Techne Corp $TECH - MarketBeat

Mar 04, 2026
pulisher
Mar 03, 2026

Bio-Techne Corp. stock outperforms competitors despite losses on the day - MarketWatch

Mar 03, 2026
pulisher
Mar 03, 2026

Bio-Techne at TD Cowen Conference: Strategic Growth and Challenges - Investing.com

Mar 03, 2026
pulisher
Mar 03, 2026

TECH Technical Analysis & ETF Price Forecast - Intellectia AI

Mar 03, 2026
pulisher
Mar 03, 2026

Segall Bryant & Hamill LLC Sells 34,680 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

Champlain Investment Partners LLC Sells 963,441 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

American Century Companies Inc. Boosts Bio-Techne Stake - National Today

Mar 03, 2026
pulisher
Mar 03, 2026

American Century Companies Inc. Grows Stock Position in Bio-Techne Corp $TECH - MarketBeat

Mar 03, 2026
pulisher
Mar 03, 2026

3 Reasons to Avoid TECH and 1 Stock to Buy Instead - Finviz

Mar 03, 2026
pulisher
Mar 03, 2026

Citigroup Trims Stake in Bio-Techne Corp - National Today

Mar 03, 2026
pulisher
Mar 02, 2026

Bio-Techne Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Mar 02, 2026
pulisher
Mar 02, 2026

Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch

Mar 02, 2026
pulisher
Mar 02, 2026

Royce & Associates Cuts Stake in Bio-Techne Corp - National Today

Mar 02, 2026
pulisher
Mar 02, 2026

Bio-Techne Corp (TECH) Stock Analysis: Potential 27.54% Upside Amidst Market Challenges - DirectorsTalk Interviews

Mar 02, 2026
pulisher
Mar 02, 2026

Bio-Techne Corp $TECH Shares Sold by Royce & Associates LP - MarketBeat

Mar 02, 2026
pulisher
Mar 01, 2026

William Blair Investment Management LLC Grows Holdings in Bio-Techne Corp $TECH - MarketBeat

Mar 01, 2026
pulisher
Mar 01, 2026

Citigroup Inc. Sells 97,843 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 01, 2026
pulisher
Feb 28, 2026

Tranche Update on Bio-Techne Corporation's Equity Buyback Plan announced on May 6, 2025. - marketscreener.com

Feb 28, 2026
pulisher
Feb 28, 2026

Will Ella CE-IVD Approval in EU Clinical Labs Change Bio-Techne's (TECH) Diagnostic Platform Narrative? - Yahoo Finance

Feb 28, 2026
pulisher
Feb 27, 2026

Bio-Techne Corp. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch

Feb 27, 2026
pulisher
Feb 27, 2026

Bio-Techne Corp $TECH Shares Sold by JPMorgan Chase & Co. - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

TECH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 27, 2026
pulisher
Feb 24, 2026

Bio-Techne Corp. stock outperforms competitors on strong trading day - MarketWatch

Feb 24, 2026
pulisher
Feb 24, 2026

Bio-Techne Corporation (TECH) Carries Attractive FY27 Organic Growth Projections - Finviz

Feb 24, 2026
pulisher
Feb 24, 2026

Bio-Techne to Present at Upcoming Investor Conferences - Finviz

Feb 24, 2026
pulisher
Feb 23, 2026

RSI Alert: Bio-Techne (TECH) Now Oversold - Nasdaq

Feb 23, 2026
pulisher
Feb 23, 2026

Medpace, Revvity, Azenta, Bio-Techne, and Oscar Health Stocks Trade Down, What You Need To Know - Yahoo Finance

Feb 23, 2026
pulisher
Feb 23, 2026

Bio-Techne Corp $TECH Holdings Trimmed by Granite Investment Partners LLC - MarketBeat

Feb 23, 2026
pulisher
Feb 23, 2026

OneDigital Investment Advisors LLC Takes Position in Bio-Techne Corp $TECH - MarketBeat

Feb 23, 2026
pulisher
Feb 23, 2026

Bio-Techne Corp (NASDAQ:TECH) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat

Feb 23, 2026
pulisher
Feb 23, 2026

Aberdeen Group plc Has $499,000 Holdings in Bio-Techne Corp $TECH - MarketBeat

Feb 23, 2026
pulisher
Feb 22, 2026

Bio-Techne Corp $TECH Shares Sold by Vanguard Group Inc. - MarketBeat

Feb 22, 2026
pulisher
Feb 21, 2026

Bio-Techne Corp $TECH Shares Sold by BNP PARIBAS ASSET MANAGEMENT Holding S.A. - MarketBeat

Feb 21, 2026
pulisher
Feb 19, 2026

TECH | Bio-Techne Corp. FinancialsIncome Statement - Quiver Quantitative

Feb 19, 2026
pulisher
Feb 19, 2026

17,441 Shares in Bio-Techne Corp $TECH Acquired by Maridea Wealth Management LLC - MarketBeat

Feb 19, 2026
pulisher
Feb 19, 2026

Evaluating Bio-Techne (TECH) After Ella’s CE-IVD Milestone And Diagnostics Growth Prospects - Yahoo Finance

Feb 19, 2026
pulisher
Feb 17, 2026

Insider plans Rule 144 sale of 1,976 Bio-Techne (TECH) shares - Stock Titan

Feb 17, 2026
pulisher
Feb 16, 2026

Bio-Techne (TECH) Gains CE-IVD Certification for Ella Platform i - GuruFocus

Feb 16, 2026
pulisher
Feb 16, 2026

Bio-Techne’s Ella platform achieves CE-IVD marking, available for sale in E.U. - TipRanks

Feb 16, 2026
pulisher
Feb 16, 2026

Bio-Techne's Ella Immunoassay Platform Receives CE-IVD Marking In EU - Nasdaq

Feb 16, 2026
pulisher
Feb 16, 2026

Bio-Techne Corp (TECH): Investor Outlook Highlights 25.56% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews

Feb 16, 2026
pulisher
Feb 16, 2026

Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge?Based Immunoassays for European Clinical Laboratories - Investing News Network

Feb 16, 2026
pulisher
Feb 16, 2026

Bio-Techne Corp's Ella platform receives CE-IVD marking, available for sale in EU - marketscreener.com

Feb 16, 2026
pulisher
Feb 16, 2026

Bio-Techne Corp's Ella Platform Receives CE-Ivd Marking, Available For Sale In EU - TradingView

Feb 16, 2026
pulisher
Feb 16, 2026

Fast biomarker test platform gets EU CE-IVD mark for hospital labs - Stock Titan

Feb 16, 2026
pulisher
Feb 15, 2026

A | Is Bio Techne Corporation showing insider buyingWeekly Stock Report & Smart Money Movement Tracker - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

Why Bio Techne Corporation stock is trending among retail tradersTake Profit & Real-Time Buy Signal Notifications - mfd.ru

Feb 14, 2026
pulisher
Feb 14, 2026

ING Groep NV Acquires Shares of 20,266 Bio-Techne Corp $TECH - MarketBeat

Feb 14, 2026

Bio Techne Corp (TECH) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$47.43
price down icon 0.11%
$29.52
price up icon 6.00%
$57.80
price up icon 15.99%
$103.80
price up icon 3.02%
$149.88
price up icon 1.96%
biotechnology ONC
$299.02
price up icon 0.67%
大文字化:     |  ボリューム (24 時間):